Robust kinetic model for quantification of P-glycoprotein (P-gp) function under altered metabolism and after P-gp inhibition using (R)[C-11]verapamil and PET

被引：0

作者：

Wang, Shaonan ^{[1
]}

Feldmann, Maria ^{[2
]}

Hinz, Rainer ^{[1
]}

McMahon, Adam ^{[1
]}

Koepp, Matthias ^{[2
]}

Jackson, Alan ^{[1
]}

Asselin, Marie-Claude ^{[1
]}

机构：

[1] Univ Manchester, Sch Canc & Enabling Sci, Wolfson Mol Imaging Ctr, Manchester M13 9PL, Lancs, England

[2] UCL, Inst Neurol, London WC1E 6BT, England

来源：

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 2012年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S169 / S170

页数：2

共 50 条

[41] Dual drug interactions via P-glycoprotein (P-gp)/ cytochrome P450 (CYP3A4) interplay: recent case study of oral atorvastatin and verapamil
Nuggehally R. Srinivas
European Journal of Clinical Pharmacology, 2008, 64 : 1135 - 1136
[42] In vitro evaluation of the new P-gp tracer [18F]MC210 and comparison to (R)-[11C]verapamil
Savolainen, Heli
Benadiba, Marcel
Kwizera, Chantal
Elsinga, Philip H.
Windhorst, Albert D.
Lammertsma, Adriaan A.
Cantore, Mariangela
Colabufo, Nicola A.
Luurtsema, Gert
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 : S334 - S334
[43] [11C]N-Desmethyl-Loperamide is an improved radiotracer for studying brain P-gp function
Zoghbi, Sami S.
Liow, J. -S.
Lazarova, N.
Hong, J.
Tuan, E.
Gladding, R. L.
Innis, R. B.
Pike, V. W.
NEUROIMAGE, 2008, 41 : T106 - T106
[44] [11C]Sorafenib: Radiosynthesis and preliminary PET study of brain uptake in P-gp/Bcrp knockout mice
Asakawa, Chiharu
Ogawa, Masanao
Kumata, Katsushi
Fujinaga, Masayuki
Kato, Koichi
Yamasaki, Tomoteru
Yui, Joji
Kawamura, Kazunori
Hatori, Akiko
Fukumura, Toshimitsu
Zhang, Ming-Rong
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (08) : 2220 - 2223
[45] Expression and function of P-glycoprotein (P-GP) on mononuclear cells in patients with rheumatoid arthritis (RA): Comparison of cells infiltrating synovial tissue to peripheral mononuclear cells
Jung, N.
Barthel, U.
Seifert, J.
Taubert, D.
Passon, D.
Lehmann, C.
Rubbert, A.
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 130 - 131
[46] Establishment of a robust hepatitis C virus replicon cell line over-expressing P-glycoprotein that facilitates analysis of P-gp drug transporter effects on inhibitor antiviral activity
Hernandez, Dennis
Falk, Paul
Yu, Fei
Zhai, Guangzhi
Quan, Yong
Faria, Teresa
Cao, Kai
Scola, Paul
McPhee, Fiona
BIOCHEMICAL PHARMACOLOGY, 2013, 85 (01) : 21 - 28
[47] Real-time measurement of rhodamine 123 (R123) transport in T-cell subsets: Kinetics of P-glycoprotein (P-gp) function in a physiological system.
Donnenberg, VS
Burckart, GJ
Nolin, TD
Donnenberg, AD
JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09) : 1068 - 1068
[48] Evaluation of (R)-[11C]verapamil as PET tracer of P-glycoprotein function in the blood-brain barrier:: kinetics and metabolism in the rat
Luurtsema, G
Molthoff, CFM
Schuit, RC
Windhorst, AD
Lammertsma, AA
Franssen, EJF
NUCLEAR MEDICINE AND BIOLOGY, 2005, 32 (01) : 87 - 93
[49] Effects of P-glycoprotein (P-GP) inhibition on the distribution of domperidone to cardiac tissue: Development of a physiologically based pharmacokinetic model in mdr1a/b(-/-) and wild type mice.
Fenneteau, F
Couture, L
Nash, JA
Turgeon, J
Nekka, F
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P49 - P49
[50] Multidrug-resistance gene 1-type p-glycoprotein (MDR1 p-gp) inhibition by tariquidar impacts on neuroendocrine and behavioral processing of stress
Thoeringer, Christoph K.
Wultsch, Thomas
Shahbazian, Anaid
Painsipp, Evelin
Holzer, Peter
PSYCHONEUROENDOCRINOLOGY, 2007, 32 (8-10) : 1028 - 1040

← 1 2 3 4 5 →